Lanreotide is a synthetic analogue of somatostatin, a naturally occurring inhibitory hormone which blocks the release of several other hormones, including growth hormone, thyroid-stimulating hormone (TSH), insulin and glucagon. Lanreotide binds to the same receptors as somatostatin, with higher affinity to peripheral receptors, and has similar activity.
|Synonyms/Alias||Angiopeptin; Autogel; BIM-23014; BIM 23014; BIM23014; DC-13-116; Ipstyl; Somatuline; Lanreotidum; Lanreotida; Lanreotide; LS-153748; LS 153748; LS153748|
|Sequence||Three Letter Code: H-D-2-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 (Disulfide bond)|
|Application||Lanreotide (INN) is a medication used in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. It is a long-acting analogue of somatostatin, like octreotide.|
|Areas of Interest||Acromegaly & Neuroendocrine tumors|
||Storage||Desiccate at -20°C
||Shipping Condition||Room temperature in continental US; may vary elsewhere.
||Long-term Storage Conditions||−20°C
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).